BCEIE › News › GILLANDERS

Results

Gillanders Arbuthnot & Company: The financial results for the period ended September 30, 2026

Gillanders Arbuthnot & Company (GILLANDERS) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹209 crore.

BCEIE News Desk · Published 13 Nov 2026, 01:35 pm IST · Filing received 13 Nov 2026, 01:17 pm IST

What happened

Gillanders Arbuthnot & Company (GILLANDERS) filed a disclosure with the exchanges on 13 November 2026 at 01:17 PM titled "The financial results for the period ended September 30, 2026".

From the filing: "Gillanders Arbuthnot & Company Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026."

Company snapshot

Gillanders Arbuthnot & Company is a micro-cap company, with a market value of about ₹209 crore.

The stock last traded at ₹98.06, against a 52-week range of ₹76–₹127.1 (22.8% below the high).

Before this filing the shares had moved −1.5% over the month and +7.0% over three months. Average daily turnover over the last 20 sessions was about ₹0.03 crore.

Promoters held 69.05% at the end of Q1 FY27.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2688-5.5-2.56
Q2 FY2613214.36.68
Q3 FY261074.52.13
Q4 FY26103-3.9-1.82
Q1 FY27912.51.18

What history shows

This is not the company's first results disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.

Market-wide, 11,743 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.
  • 13 November 2026: Board meeting — Financial Results.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.